Charlie Harrison is President and Founder of Critical Strategies, LLC, a company providing commercial, strategic and interim leadership support to life science clients since 2001. Through Critical Strategies, Charlie has served as President and Chief Operating Officer of Medical Compression Systems, Inc. (MCS) since September 2009. MCS is the US subsidiary of Medical Compression Systems, Ltd., an Israel-based medical device company focused innovative, non-invasive solutions for the prevention of venous thromboembolism (VTE). Prior to joining MCS Management, Charlie was President, CFO, Director and a Founder of Wynden Pharmaceuticals, Inc., a private pharmaceutical company focused on electrolyte management, and also served as a Director of Medical Compression Systems Ltd. from 2004 to 2009.
Early in his career, Charlie led Organon Pharmaceuticals’ entry into the surgical muscle relaxant business. Charlie then shifted to lead marketing for Organon Diagnostics and, subsequently, for a division of SmithKline. After SmithKline, Charlie became President, CFO and a Director of Unimed, Inc., a specialty pharmaceutical company focused on Cancer and AIDS therapies. Subsequently, he served as CEO in the launch of Creative Products Resource, a development company focused on dermatological and other consumer products that was ultimately sold to Dial Corporation.
From 1996 to 2000, Charlie ran the therapeutics business of Serologicals Corp., a division he grew to revenues in excess of $100 million through organic growth and acquisitions. Charlie served as the Chairman of the Chamber’s Medical Committee, from 2007 to 2009, as a member of the Chamber’s Board, from 2002 to Present, a member of the Chamber’s Executive Committee, from 2003 to Present, and as Chairman of the Chamber’s Board, from 2009 to 2011. Charlie also serves as a Director of SEMDA, the Southeast Medical Device Association. Charlie received his B.S. in Mathematics from Pennsylvania State University and his MBA from the University of Massachusetts.